Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Standard effective doses for proliferative tumours.

L C Jones1, P Metcalfe, P Hoban

  • 1Department of Medical Physics, Prince of Wales Hospital, Randwick, NSW, Australia. lois.jones@swsahs.nsw.gov.au

Physics in Medicine and Biology
|September 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The World Health Organisation's Global Strategy and Action Plan on Oral Health: A Collaborative Response From Oral Health Professionals' Education Associations.

European journal of dental education : official journal of the Association for Dental Education in Europe·2025
Same author

The IADR and AADOCR Policy Statement on Tobacco Industry-Funded Research.

Journal of dental research·2025
Same author

Exploring health and social care preferences for people with dementia and mild cognitive impairment: a systematic review of discrete choice experiments.

Aging & mental health·2025
Same author

Automated detection, delineation and quantification of whole-body bone metastasis using FDG-PET/CT images.

Physical and engineering sciences in medicine·2023
Same author

High-resolution entry and exit surface dosimetry in a 1.5 T MR-linac.

Physical and engineering sciences in medicine·2023
Same author

Augmented Reality From the Benchtop to the Practice of Joint Arthroplasty: Is It Feasible?

The Journal of arthroplasty·2022

Investigating radiation therapy schedules for fast-growing tumors reveals that accelerated regimens offer benefits only for tumors with very short doubling times. Higher doses improve tumor control but also increase acute side effects, limiting the use of some accelerated schedules.

Area of Science:

  • Radiation oncology
  • Medical physics
  • Cancer research

Background:

  • Clinical treatment schedules for highly proliferative tumors vary in fraction size, number, and duration.
  • Non-standard regimens like accelerated and hyperfractionated schedules are under investigation in randomized trials.
  • The linear quadratic model is a key tool for analyzing radiation therapy effects.

Purpose of the Study:

  • To compare non-standard and standard radiation therapy regimens for highly proliferative tumors.
  • To evaluate the impact of fraction size, number, and duration on treatment outcomes.
  • To assess the efficacy and toxicity of different fractionation schedules using novel parameters.

Main Methods:

  • Utilized the linear quadratic model with a time component to analyze treatment regimens.

Related Experiment Videos

  • Calculated proliferative standard effective dose one (PSED1) and proliferative standard effective dose two (PSED2) for various schedules.
  • Generated graphs of PSED1 and PSED2 against potential doubling time (Tp) for regimens in randomized trials.

    • Main Results:

    • Highly accelerated schedules, such as CHART, demonstrate advantages primarily for tumors with very short potential doubling times.
    • Calculations indicated that most considered schedules provide at least equivalent tumor control compared to control arms.
    • Increased PSED1 or PSED2 values correlated with enhanced tumor control, but also with higher acute side effects.

    Conclusions:

    • The effectiveness of accelerated radiation schedules is highly dependent on tumor potential doubling time.
    • While advanced schedules can improve tumor control, they may lead to unacceptable acute toxicities.
    • The findings align with current clinical observations regarding the balance between efficacy and toxicity in radiation therapy.